BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $103,000 | -29.9% | 158,000 | -13.7% | 0.00% | -50.0% |
| Q4 2018 | $147,000 | +10.5% | 183,000 | +48.8% | 0.00% | +100.0% |
| Q3 2018 | $133,000 | -55.4% | 123,000 | 0.0% | 0.00% | -66.7% |
| Q2 2018 | $298,000 | +520.8% | 123,000 | +434.8% | 0.00% | +200.0% |
| Q1 2018 | $48,000 | -18.6% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $59,000 | -76.0% | 23,000 | -77.0% | 0.00% | -75.0% |
| Q1 2016 | $246,000 | -16.9% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $296,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 4,859,885 | $11,955,000 | 0.64% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $246,000 | 0.00% |
| Alyeska Investment Group, L.P. | 143,985 | $354,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31,792 | $78,000 | 0.00% |
| Geneva Advisors, LLC | 12,500 | $31,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $2,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 28,379 | $70,000 | 0.00% |
| Walleye Trading LLC | 700 | $2,000 | 0.00% |
| LPL Financial LLC | 61,246 | $131,000 | 0.00% |